Search
for
Sort by
Research 601–630 of 1000+
- Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.
- Androgen- and Estrogen-Secreting Adrenal Cancers
- Dermatological manifestations in patients with chronic kidney disease
- Treatment of chemotherapy-induced alopecia
- Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Cervical cancer metastasis to the scalp presenting as alopecia neoplastica
- Epigenetic regulation in adult stem cells and cancers
- Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel
- Hairy Pinnae after Orchiectomy and Chemotherapy for Testicular Cancer: Acquired Localized Hypertrichosis of the Ears
- Breast Cancer-Related Neoplastic Alopecia: A Case Report and Review of the Literature
- Manejo de alopecia no paciente em tratamento oncológico
- TREATMENT PEARLS FROM EUROPE
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- The Breast Cancer Wars: Fear, Hope and the Pursuit of a Cure in Twentieth Century America
- Potential PRP Hair Treatment Side Effects
- Nonmelanoma skin cancer treated with electronic brachytherapy: Results at 1 year
- Prostate Cancer Early Detection, Version 2.2015
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Three-Month Treatment With a Long-Acting Gonadotropin-Releasing Hormone Agonist of Patients With Benign Prostatic Hyperplasia: Effects on Tissue Androgen Concentration, 5<i>α</i>-Reductase Activity and Androgen Receptor Content*
- Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression